UniProt ID | RXRA_MOUSE | |
---|---|---|
UniProt AC | P28700 | |
Protein Name | Retinoic acid receptor RXR-alpha | |
Gene Name | Rxra | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 467 | |
Subcellular Localization | Nucleus. | |
Protein Description | Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. RXRA serves as a common heterodimeric partner for a number of nuclear receptors. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes.. | |
Protein Sequence | MDTKHFLPLDFSTQVNSSSLNSPTGRGSMAVPSLHPSLGPGIGSPLGSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFGTGSPQLNSPMNPVSSTEDIKPPLGLNGVLKVPAHPSGNMASFTKHICAICGDRSSGKHYGVYSCEGCKGFFKRTVRKDLTYTCRDNKDCLIDKRQRNRCQYCRYQKCLAMGMKREAVQEERQRGKDRNENEVESTSSANEDMPVEKILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQAT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Ubiquitination | ----MDTKHFLPLDF ----CCCCCCCCCCC | 28.26 | - | |
17 | Phosphorylation | DFSTQVNSSSLNSPT CCCCCCCCCCCCCCC | 23.58 | 25619855 | |
18 | Phosphorylation | FSTQVNSSSLNSPTG CCCCCCCCCCCCCCC | 33.37 | 25619855 | |
19 | Phosphorylation | STQVNSSSLNSPTGR CCCCCCCCCCCCCCC | 31.24 | 25619855 | |
22 | Phosphorylation | VNSSSLNSPTGRGSM CCCCCCCCCCCCCCC | 29.18 | 25521595 | |
24 | Phosphorylation | SSSLNSPTGRGSMAV CCCCCCCCCCCCCCC | 39.05 | 25619855 | |
28 | Phosphorylation | NSPTGRGSMAVPSLH CCCCCCCCCCCCCCC | 11.38 | - | |
61 | Phosphorylation | SPISTLSSPINGMGP CCCHHCCCCCCCCCC | 32.67 | 10383391 | |
75 | Phosphorylation | PPFSVISSPMGPHSM CCCEEEECCCCCCCC | 14.05 | 10383391 | |
87 | Phosphorylation | HSMSVPTTPTLGFGT CCCCCCCCCCCCCCC | 14.27 | 10383391 | |
134 | Phosphorylation | HPSGNMASFTKHICA CCCCCHHHHHHEEEH | 23.76 | - | |
150 | Acetylation | CGDRSSGKHYGVYSC CCCCCCCCEEEEEEC | 35.28 | - | |
229 | Phosphorylation | ENEVESTSSANEDMP CCCCCCCCCCCCCCC | 36.41 | 23684622 | |
230 | Phosphorylation | NEVESTSSANEDMPV CCCCCCCCCCCCCCH | 34.89 | 23684622 | |
264 | Phosphorylation | ANMGLNPSSPNDPVT ECCCCCCCCCCCHHH | 58.30 | 29472430 | |
265 | Phosphorylation | NMGLNPSSPNDPVTN CCCCCCCCCCCHHHH | 29.04 | 10383391 | |
271 | Phosphorylation | SSPNDPVTNICQAAD CCCCCHHHHHHHHHH | 25.01 | 23140645 | |
386 | Ubiquitination | VLFNPDSKGLSNPAE ECCCCCCCCCCCHHH | 71.85 | - | |
422 | Ubiquitination | EQPGRFAKLLLRLPA CCCCHHHHHHHHHHH | 36.63 | - | |
432 | O-linked_Glycosylation | LRLPALRSIGLKCLE HHHHHHHHHHHHHHH | 23.12 | 30059200 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
61 | S | Phosphorylation | Kinase | JNK1 | Q91Y86 | PSP |
61 | S | Phosphorylation | Kinase | JNK2 | Q9WTU6 | PSP |
75 | S | Phosphorylation | Kinase | JNK1 | Q91Y86 | PSP |
75 | S | Phosphorylation | Kinase | JNK2 | Q9WTU6 | PSP |
87 | T | Phosphorylation | Kinase | JNK1 | Q91Y86 | PSP |
87 | T | Phosphorylation | Kinase | JNK2 | Q9WTU6 | PSP |
265 | S | Phosphorylation | Kinase | JNK1 | Q91Y86 | PSP |
265 | S | Phosphorylation | Kinase | JNK2 | Q9WTU6 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RXRA_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NR1H3_MOUSE | Nr1h3 | physical | 20211142 | |
SFPQ_HUMAN | SFPQ | physical | 11259580 | |
NONO_HUMAN | NONO | physical | 11259580 | |
SIN3A_HUMAN | SIN3A | physical | 11259580 | |
NR1H4_MOUSE | Nr1h4 | physical | 19883617 | |
TGIF1_MOUSE | Tgif1 | physical | 16428452 | |
SMRD3_HUMAN | SMARCD3 | physical | 14701856 | |
EP300_HUMAN | EP300 | physical | 14701856 | |
TIF1A_MOUSE | Trim24 | physical | 7744009 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"The phosphorylation site located in the A region of retinoic Xreceptor alpha is required for the antiproliferative effect ofretinoic acid (RA) and the activation of RA target genes in F9cells."; Bastien J., Adam-Stitah S., Plassat J.L., Chambon P.,Rochette-Egly C.; J. Biol. Chem. 277:28683-28689(2002). Cited for: PHOSPHORYLATION AT SER-22, FUNCTION, AND MUTAGENESIS OF SER-22. | |
"Hyperphosphorylation of the retinoid X receptor alpha by activated c-Jun NH2-terminal kinases."; Adam-Stitah S., Penna L., Chambon P., Rochette-Egly C.; J. Biol. Chem. 274:18932-18941(1999). Cited for: PHOSPHORYLATION AT SER-22; SER-61; SER-75; THR-87 AND SER-265,FUNCTION, AND MUTAGENENESIS OF SER-22; SER-44; SER-48; SER-54; SER-61;SER-75; THR-87; SER-96; SER-101 AND SER-265. |